Present study was designed for assessment impact of intravenous methylprednisolone on postoperative pain in Intertrochanteric fracture. 40-70 years patients with Intertrochanteric fracture were included and randomly allocated into the trial and control groups. Thirty minutes before operation, patients received one dosage of methylprednisolone (2 cc, 125 mg) in trial group and 2 cc normal saline (isotonic saline) in control group. Postoperative pain in patients was assessed by VAS at 4, 6, 12, 36 and 48 hours after operation. Nausea and vomiting and CRP level were measured and compared with control group.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT2013051113182N1
Registration date:2013-09-21, 1392/06/30
Registration timing:registered_while_recruiting
Last update:
Update count:0
Registration date
2013-09-21, 1392/06/30
Registrant information
Name
Amir Bahrami-Ahmadi
Name of organization / entity
Iran University of Medical Sciences
Country
Iran (Islamic Republic of)
Phone
+98 912 496 9707
Email address
bahramia@gmail.com
Recruitment status
Recruitment complete
Funding source
Tehran University of Medical Sciences
Expected recruitment start date
2012-10-01, 1391/07/10
Expected recruitment end date
2014-10-02, 1393/07/10
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Effect of Intravenous methylprednisolon on postoperative pain in patients with intertrochanteric femur fracture
Public title
Effect of methylprednisolon on postoperative pain in femur Fracture
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:age between 40-70; having writing and verbal ability;
Exclusion criteria:S-A contraindication; Failure in previous S-A; having renal failure;having peptic ulcer; having diabetes I or II; Neuropathy in RA patients that have steroid or immunosupressive usage in previous 6 months; Marcaine, Methyl prednisolon, fenatanile sensitivity;Alcoholism;smoking/addiction;pregnant women